PNC Financial Services Group’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-372
Closed -$997 4862
2022
Q4
$997 Buy
+372
New +$981 ﹤0.01% 4411
2021
Q3
Sell
-94
Closed -$4K 4447
2021
Q2
$4K Sell
94
-43
-31% -$1.99K ﹤0.01% 3951
2021
Q1
$7K Buy
137
+126
+1,145% +$8.59K ﹤0.01% 3756
2020
Q4
$1K Buy
+11
New +$925 ﹤0.01% 3931

Other funds holding CELL

PNC Financial Services Group's CELL Position: Q1 2023 in Review

PNC Financial Services Group sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2023, closing a stake of 372 shares — an estimated $997 sold.

PNC Financial Services Group first reported a position in CELL in Q4 2020 and held it in 4 quarters. The position peaked at $7K in Q1 2021. 102 funds tracked by Wall St. Rank hold CELL as of Q1 2023.

  • PNC Financial Services Group reported no remaining PhenomeX Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 372 PhenomeX Inc. Common Stock shares in Q1 2023, an estimated $997.
  • PNC Financial Services Group first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • PNC Financial Services Group's PhenomeX Inc. Common Stock position peaked at $7K in Q1 2021.
  • 102 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.